BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 31400707)

  • 1. Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors.
    Romagnoli R; Oliva P; Salvador MK; Camacho ME; Padroni C; Brancale A; Ferla S; Hamel E; Ronca R; Grillo E; Bortolozzi R; Rruga F; Mariotto E; Viola G
    Eur J Med Chem; 2019 Nov; 181():111577. PubMed ID: 31400707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents.
    Romagnoli R; Oliva P; Salvador MK; Manfredini S; Padroni C; Brancale A; Ferla S; Hamel E; Ronca R; Maccarinelli F; Rruga F; Mariotto E; Viola G; Bortolozzi R
    Eur J Med Chem; 2021 Mar; 214():113229. PubMed ID: 33550186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
    Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
    Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of (1-aryl-1H-pyrazol-4-yl) (3,4,5-trimethoxyphenyl)methanone derivatives as tubulin inhibitors.
    Zhai M; Wang L; Liu S; Wang L; Yan P; Wang J; Zhang J; Guo H; Guan Q; Bao K; Wu Y; Zhang W
    Eur J Med Chem; 2018 Aug; 156():137-147. PubMed ID: 30006160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity.
    Xu Q; Qi H; Sun M; Zuo D; Jiang X; Wen Z; Wang Z; Wu Y; Zhang W
    PLoS One; 2015; 10(6):e0128710. PubMed ID: 26061410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents.
    Romagnoli R; Baraldi PG; Prencipe F; Oliva P; Baraldi S; Salvador MK; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Ronca R; Bortolozzi R; Mariotto E; Porcù E; Basso G; Viola G
    Sci Rep; 2017 Apr; 7():46356. PubMed ID: 28406191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors.
    Oliva P; Romagnoli R; Manfredini S; Brancale A; Ferla S; Hamel E; Ronca R; Maccarinelli F; Giacomini A; Rruga F; Mariotto E; Viola G; Bortolozzi R
    Eur J Med Chem; 2020 Aug; 200():112448. PubMed ID: 32417696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
    Mustafa M; Abdelhamid D; Abdelhafez EMN; Ibrahim MAA; Gamal-Eldeen AM; Aly OM
    Eur J Med Chem; 2017 Dec; 141():293-305. PubMed ID: 29031074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
    Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
    J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.
    Romagnoli R; Baraldi PG; Cruz-Lopez O; Lopez Cara C; Carrion MD; Brancale A; Hamel E; Chen L; Bortolozzi R; Basso G; Viola G
    J Med Chem; 2010 May; 53(10):4248-58. PubMed ID: 20420439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isocombretastatins A: 1,1-diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds.
    Alvarez R; Alvarez C; Mollinedo F; Sierra BG; Medarde M; Peláez R
    Bioorg Med Chem; 2009 Sep; 17(17):6422-31. PubMed ID: 19647439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cyanocombretastatins as potent tubulin polymerisation inhibitors.
    Jalily PH; Hadfield JA; Hirst N; Rossington SB
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6731-4. PubMed ID: 23010271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
    Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
    Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole.
    Romagnoli R; Baraldi PG; Prencipe F; Oliva P; Baraldi S; Tabrizi MA; Lopez-Cara LC; Ferla S; Brancale A; Hamel E; Ronca R; Bortolozzi R; Mariotto E; Basso G; Viola G
    Sci Rep; 2016 May; 6():26602. PubMed ID: 27216165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution at the indole 3 position yields highly potent indolecombretastatins against human tumor cells.
    Álvarez R; Gajate C; Puebla P; Mollinedo F; Medarde M; Peláez R
    Eur J Med Chem; 2018 Oct; 158():167-183. PubMed ID: 30216850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microwave-assisted synthesis and biological evaluation of 3,4-diaryl maleic anhydride/N-substituted maleimide derivatives as combretastatin A-4 analogues.
    Guan Q; Zuo D; Jiang N; Qi H; Zhai Y; Bai Z; Feng D; Yang L; Jiang M; Bao K; Li C; Wu Y; Zhang W
    Bioorg Med Chem Lett; 2015 Feb; 25(3):631-4. PubMed ID: 25529737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors.
    Liu R; Huang M; Zhang S; Li L; Li M; Sun J; Wu L; Guan Q; Zhang W
    Eur J Med Chem; 2021 Dec; 226():113826. PubMed ID: 34571171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
    Sharma S; Gupta MK; Saxena AK; Bedi PM
    Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of hydrogen-bonding propensity and anticancer profile of tetrazole-tethered combretastatin analogues.
    Jedhe GS; Paul D; Gonnade RG; Santra MK; Hamel E; Nguyen TL; Sanjayan GJ
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4680-4. PubMed ID: 23809851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
    Subba Rao AV; Swapna K; Shaik SP; Lakshma Nayak V; Srinivasa Reddy T; Sunkari S; Shaik TB; Bagul C; Kamal A
    Bioorg Med Chem; 2017 Feb; 25(3):977-999. PubMed ID: 28034647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.